# 2026-20169: DOT Eyes New Rules for Bizarre Drug Test Urine pH and Medical Proof Deadlines

2026-20169, Petition for Rulemaking; Notification of Petition for Rulemaking; Invalid Specimen Determinations, is a Federal Register proposed rule from Transportation Department published 2026-10-01, effective DOT will accept comments, data, and information with respect to the Darcy Kern Petition until November 2, 2026.; PRIA reads it as touching household money (as of 2026-10-08).

- Canonical: https://policyrisk.com/federal-register/2026-20169
- As of: 2026-10-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-20169
- Title: Petition for Rulemaking; Notification of Petition for Rulemaking; Invalid Specimen Determinations
- Type: Proposed Rule
- Agencies: Transportation Department
- Citation: 91 FR 62409
- Published: 2026-10-01
- Effective: DOT will accept comments, data, and information with respect to the Darcy Kern Petition until November 2, 2026.
- Comments close: 2026-11-02
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-10-08

## In one line

DOT Eyes New Rules for Bizarre Drug Test Urine pH and Medical Proof Deadlines

## Summary

The Department of Transportation got a petition asking to change drug testing rules for workers. The changes would add clear medical checks when test results look weird, like odd urine pH levels, and set deadlines for submitting medical proof. If approved, this could affect employees and medical reviewers, with public comments open until November 2, 2026—so get ready to weigh in!

## Abstract

This document announces receipt of a petition for rulemaking received by DOT on February 27, 2026, to initiate a rulemaking to amend 49 CFR part 40. The petitioner's proposed amendments seek to incorporate structured medical verification standards when an employee asserts a plausible medical explanation for abnormal specimen validity findings, including abnormal pH values. Specifically, the petitioner proposes: a defined and finite documentation submission window; required written Medical Review Officer determinations addressing submitted documentation; defined evaluation standards for abnormal urinary chemistry findings; consideration of specialist consultation when diagnosed voiding disorders are asserted; and (5) documented review of medically supported functional voiding disorders prior to verifying refusal determinations based on inability to provide a specimen under direct observation. Through this notification, DOT seeks comment on the petition, as well as any information that could be used in DOT's determination whether to grant the petition.

## Effects PRIA read

- 72-hour medical-document window: benefit, high. The petition proposes that when an employee claims a medical reason for an abnormal drug-test specimen (including abnormal urine pH), the Medical Review Officer (MRO) must give the employee up to 72 hours to submit documentation from a licensed medical provider supporting that claim.
- Written MRO determination before observed recollection: benefit, medium. The petition proposes that the MRO must issue a written determination addressing any submitted medical documentation before directing a directly observed recollection under existing rules.
- Defined standards for abnormal urine chemistry: benefit, medium. The petition proposes adding defined evaluation standards for abnormal urinary chemistry findings (including abnormal pH values) to guide MRO determinations when medical explanations are asserted.
- Specialist consultation for voiding disorders: benefit, low. The petition proposes that when an asserted medical explanation involves a diagnosed urological condition or functional voiding disorder (including paruresis), the MRO should consider consulting a licensed urologist or a licensed mental health professional familiar with such conditions before issui…
- Document medical review before verifying refusals: benefit, medium. The petition proposes that before verifying a refusal to test based on failure to provide a sufficient specimen under direct observation, the MRO must document consideration of any previously submitted medical documentation showing a functional voiding disorder that could impair providing a specime…

## Related documents

- [2026-22617](https://policyrisk.com/federal-register/2026-22617): Deepwater Port Application Processing and Licensing, 2026-11-05
- [2026-22396](https://policyrisk.com/federal-register/2026-22396): Pipeline Safety: Amendments to Liquefied Natural Gas Facilities, 2026-11-03
- [2026-21794](https://policyrisk.com/federal-register/2026-21794): Federal Motor Vehicle Safety Standards; Modernization of FMVSS No. 108 To Accommodate ADS-Equipped Vehicles, 2026-10-26
- [2026-21058](https://policyrisk.com/federal-register/2026-21058): Cause of Airline Delay and Cancellation Categories Under Section 511(b) of the FAA Reauthorization Act of 2024; Delay of Effective Date, 2026-10-15
- [2026-19964](https://policyrisk.com/federal-register/2026-19964): The Safer Affordable Fuel-Efficient (SAFE) Vehicles Rule III for Model Years 2022 to 2031 Passenger Cars and Light Trucks, 2026-09-30
- [2026-18040](https://policyrisk.com/federal-register/2026-18040): Cause of Airline Delay and Cancellation Categories Under Section 511(b) of the FAA Reauthorization Act of 2024, 2026-09-03

## Sources
- [2026-20169 on federalregister.gov](https://www.federalregister.gov/documents/2026/10/01/2026-20169/petition-for-rulemaking-notification-of-petition-for-rulemaking-invalid-specimen-determinations)
- [2026-20169 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-10-01/pdf/2026-20169.pdf)

## Related
- [Previous: 2026-20143, Rule on Impersonation of Government and Businesses](https://policyrisk.com/federal-register/2026-20143)
- [Next: 2026-20202, Amendment of Class D and E Airspace, Revocation of Class E Airspace; Montgomery…](https://policyrisk.com/federal-register/2026-20202)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-20169 (as of 2026-10-08).
